Caris Life Sciences to Report Third Quarter 2025 Financial Results on November 5, 2025
Caris Life Sciences (NASDAQ: CAI) announced it will report third quarter 2025 financial results on Wednesday, November 5, 2025.
The company will host a conference call and live webcast on November 5 at 3:30 p.m. CT (4:30 p.m. ET) to discuss results. Investors can join the live webcast at https://edge.media-server.com/mmc/p/uwjxydsa. A replay will be available shortly after the call on the Investor Relations section of CarisLifeSciences.com.
Caris Life Sciences (NASDAQ: CAI) ha annunciato che riporterà i risultati finanziari del terzo trimestre 2025 il mercoledì 5 novembre 2025.
L'azienda terrà una conference call e una webcast in diretta il 5 novembre alle 15:30 CT (16:30 ET) per discutere i risultati. Gli investitori possono partecipare alla webcast in diretta all'indirizzo https://edge.media-server.com/mmc/p/uwjxydsa. Una replica sarà disponibile poco dopo la chiamata nella sezione Relazioni con gli investitori di CarisLifeSciences.com.
Caris Life Sciences (NASDAQ: CAI) anunció que reportará los resultados financieros del tercer trimestre de 2025 en miércoles 5 de noviembre de 2025.
La empresa organizará una llamada de conferencia y una retransmisión en directo el 5 de noviembre a las 3:30 p.m. CT (4:30 p.m. ET) para discutir los resultados. Los inversores pueden unirse a la retransmisión en directo en https://edge.media-server.com/mmc/p/uwjxydsa. Una repetición estará disponible poco después de la llamada en la sección de Relaciones con Inversores de CarisLifeSciences.com.
Caris Life Sciences (NASDAQ: CAI)는 2025년 3분기 재무 실적을 2025년 11월 5일 수요일에 발표한다고 밝혔다.
회사는 재무 결과를 논의하기 위해 11월 5일 오후 3시 30분 CT(오후 4시 30분 ET)에 컨퍼런스 콜과 라이브 웹캐스트를 주최한다. 투자자들은 https://edge.media-server.com/mmc/p/uwjxydsa에서 라이브 웹캐스트에 참여할 수 있다. 콜 이후 곧 CarisLifeSciences.com의 투자자 관계 섹션에서 재생을 이용할 수 있다.
Caris Life Sciences (NASDAQ: CAI) a annoncé qu'il publiera les résultats financiers du troisième trimestre 2025 le mercredi 5 novembre 2025.
L'entreprise organisera une conférence téléphonique et une diffusion en direct le 5 novembre à 15h30 CT (16h30 HE) pour discuter des résultats. Les investisseurs peuvent rejoindre la diffusion en direct à l'adresse https://edge.media-server.com/mmc/p/uwjxydsa. Une rediffusion sera disponible peu après l'appel dans la section Relations investisseurs de CarisLifeSciences.com.
Caris Life Sciences (NASDAQ: CAI) gab bekannt, dass es die Finanzergebnisse des dritten Quartals 2025 am Mittwoch, dem 5. November 2025 bekannt geben wird.
Das Unternehmen wird am 5. November eine Telefonkonferenz und einen Live-Webcast abhalten, um die Ergebnisse zu besprechen, 15:30 Uhr CT (16:30 Uhr ET) zu diskutieren. Investoren können dem Live-Webcast unter https://edge.media-server.com/mmc/p/uwjxydsa beitreten. Eine Wiederholung wird kurz nach dem Anruf im Bereich Investor Relations von CarisLifeSciences.com verfügbar sein.
Caris Life Sciences (NASDAQ: CAI) أعلنت أن نتائجها المالية عن الربع الثالث من 2025 ستُعلن في الأربعاء 5 نوفمبر 2025.
ستستضيف الشركة مكالمة جماعية وبثاً مباشراً في 5 نوفمبر الساعة 3:30 مساءً بتوقيت CT (4:30 مساءً بتوقيت ET) لمناقشة النتائج. يمكن للمستثمرين الانضمام إلى البث المباشر على https://edge.media-server.com/mmc/p/uwjxydsa. ستتوفر إعادة العرض بعد الاتصال مباشرة في قسم علاقات المستثمرين على CarisLifeSciences.com.
Caris Life Sciences (NASDAQ: CAI) 宣布将于2025年第三季度的财报日期在2025年11月5日星期三公布。
公司将于11月5日举行电话会议和实时网络直播，以讨论结果，时间为下午3:30 CST（晚上4:30 EST）。投资者可以在https://edge.media-server.com/mmc/p/uwjxydsa收看实时网络直播。会后不久，在CarisLifeSciences.com的投资者关系栏目中将提供回放。
- None.
- None.
Caris Life Sciences will host a conference call and live webcast at 3:30 p.m. CT (4:30 p.m. ET) to discuss the financial results.
Conference Call Details:
Date: Wednesday, November 5, 2025
Time: 3:30 p.m. CT (4:30 p.m. ET)
Live Webcast: https://edge.media-server.com/mmc/p/uwjxydsa
A replay of the webcast will be available shortly after the conclusion of the call on the Investor Relations section of the Caris Life Sciences website at CarisLifeSciences.com.
About Caris Life Sciences
Caris Life Sciences® (Caris) is a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer that is actively developing and commercializing innovative solutions to transform healthcare. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced AI and machine learning algorithms at scale, Caris has created the large-scale, multimodal clinico-genomic database and computing capability needed to analyze and further unravel the molecular complexity of disease. This convergence of next-generation sequencing, AI and machine learning technologies, and high-performance computing provides a differentiated platform to develop the latest generation of advanced precision medicine diagnostic solutions for early detection, diagnosis, monitoring, therapy selection and drug development.
Caris was founded with a vision to realize the potential of precision medicine in order to improve the human condition. Headquartered in
Caris Life Sciences Media:
Corporate Communications
CorpComm@CarisLS.com
214.294.5606
Investor Relations:
InvestorRelations@CarisLS.com
917.689.3511
View original content to download multimedia:https://www.prnewswire.com/news-releases/caris-life-sciences-to-report-third-quarter-2025-financial-results-on-november-5-2025-302592156.html
SOURCE Caris Life Sciences
FAQ
When will Caris Life Sciences (CAI) report Q3 2025 results?
What time is the Caris Life Sciences (CAI) Q3 2025 earnings call?
Where can I listen to the Caris Life Sciences (CAI) live webcast for Q3 2025?
Will a replay of the Caris Life Sciences (CAI) Q3 2025 webcast be available?
How can investors access materials for Caris Life Sciences (CAI) Q3 2025 results?
